The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia

Br J Haematol. 2018 Mar;180(6):915-918. doi: 10.1111/bjh.14490. Epub 2016 Dec 26.
No abstract available

Keywords: PML/RARA; acute leukaemia; acute promyelocytic leukaemia; minimal residual disease; quantitative PCR.

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Child
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Leukemia, Promyelocytic, Acute / blood*
  • Leukemia, Promyelocytic, Acute / mortality*
  • Leukemia, Promyelocytic, Acute / therapy
  • Male
  • Middle Aged
  • Monitoring, Physiologic
  • Neoplasm, Residual
  • Survival Rate